PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Steady Stream of Device Innovations Help Endovascular Surgery Trump Conventional Methods - Endovascular abdominal aortic aneurysms emerge as a large application market for endovascular stents -
Steady Stream of Device Innovations Help Endovascular Surgery Trump Conventional Methods


NewswireToday - /newswire/ - Mountain View, CA, United States, 2011/09/23 - Endovascular abdominal aortic aneurysms emerge as a large application market for endovascular stents -

Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


The rapid discovery of treatments for vascular diseases demands rapid development of device initiatives. The recent introduction of intravascular balloons, stents and coils have popularized new therapies as alternatives to traditional surgeries such as coronary artery bypass surgery (CABG), carotid endarterectomy, and aneurysm clipping.

New developments in stent graft technology like low profile stent grafts, more flexible delivery systems, and increasingly reliable methods of branch attachment have emerged as potential options. The use of special covered stents to seal off defects in blood vessels for endovascular repair of aortic aneurysms using materials known as embolics is increasing.

New analysis from Frost & Sullivan's ( Endovascular Surgical Intervention - Technology Market Penetration Analysis research finds that the global market for endovascular abdominal aortic aneurysm (AAA) repair, which was valued at $1 billion in 2010, is expected to reach $1.6 billion by 2015.

If you are interested in more information on this study, please send an email to Britni Myers, Corporate Communications, at britni.myers[.], with your full name, company name, title, telephone number, company email address, company Website, city, state and country.

Further, this constant availability of innovative products in the market has helped to drive back the trend of price erosion and aided market expansion. Constant innovations have facilitated and promoted endovascular surgery techniques and are currently undergoing testing for their long-term outcomes and complications.

"Several clinical trials are underway, including carotid revascularization endarterectomy versus stent trial (CREST) and international subarachnoid aneurysm trial (ISAT), to assess the long-term effects of the procedures," said Technical Insights Senior Research Analyst Prasanna Vadhana Kannan. "The most common and advanced form of endovascular surgery is an endovascular aneurysm repair (EVAR)."

There are more than 2,500 active endovascular surgeons worldwide, and they comprise the primary market for endovascular surgical interventional devices. Apart from the spate of product innovations, the advancement of the Japanese market has ensured continued double-digit growth in recent years.

Endovascular surgical techniques are expected to find considerable application in AAA, with approximately 4.5 million people estimated to be suffering from it in the developed world. Of these cases, the United States alone accounts for 1.5 million and, each year, the country diagnoses 600,000 new cases.

Endovascular repair has also become a widely accepted treatment for aortic aneurysms, with penetration rates reaching 80 percent in the best centers; however, overall penetration rates in the developed world are still below 30 percent. One effective way to increase the penetration rates of vascular therapy is using informative Web portals to educate patients about the various diagnostic and therapeutic options available to them.

The importance of greater patient awareness becomes evident when, despite increased patient screening for aneurysms, the lack of understanding of AAAs often results in late detections. Even if an aneurysm is identified, due to the tortuosity of the infrarenal necks, close to 60 percent of female patients and 30 percent of male patients have anatomical features unsuited to an AAA stent graft.

"Owing to the risks of endoleaks and migration, most stent grafts are only applicable for patients with an aneurysm developing in certain locations of the abdominal aorta; in other cases, open cavity bypass surgeries are still the preferred method of treatment," said Technical Insights Senior Research Analyst Darshana De. "Moreover, due to the different sizes of the main and descending legs of the aorta, some patients might not have an anatomy that permits the use of devices that are currently available."

For patients who are treatable using graft techniques, the chances of morbidity are 11 percent less than in open endovascular surgeries.

As conventional management of clinically significant aortic aneurysm consists of surgical excision, it results in a high peri-operative mortality rate. This has led to the emergence of endovascular prosthesis as a minimally invasive, catheter-based alternative to open surgical excision. These minimally invasive devices, in the form of endovascular stent grafts, are deployed across the aneurysm in a way that the aneurysm is effectively excluded from the circulation, with subsequent restoration of normal blood flow.

Post-operative recovery in the intensive care unit is rarely required after the insertion of endovascular stents as the grafts are characterized by reduced blood transfusion requirements and hospital stays. Further, patients return to pre-intervention levels of activity more rapidly post usage of endovascular stent grafts for AAA repair.

Endovascular Surgical Intervention - Technology Market Penetration Analysis, a part of the Technical Insights subscription, identifies the emerging developments in the field of endovascular surgery and devices on a global scale. This research provides a snapshot of the global corporate and academic initiatives, a Porters five forces analysis of the competitive behavior in the industry, strategic initiatives needed, and a technology adoption cycle from the developer's perspective. Further, this research service includes detailed technology analysis and industry trends evaluated following extensive interviews with market participants.

Frost & Sullivan's Technical Insights research group is an international technology analysis business that produces a variety of technical news alerts, newsletters and research services.

About Frost & Sullivan
Frost & Sullivan (, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.

Endovascular Surgical Intervention - Technology Market Penetration Analysis / D29B

Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: Frost & Sullivan


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick Newswire Today Visibility Checker


Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

# # #
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!

Steady Stream of Device Innovations Help Endovascular Surgery Trump Conventional Methods

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Publisher Contact: Britni Myers 
210-477-8481 britni.myers[.]
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From Frost & Sullivan / Company Profile

Read Medical Services/Equipment Most Recent Related Newswires:

ZOLL Canada Wins Tender to Equip Province of Québec Paramedic Services with ZOLL X Series Monitor/Defibrillators
Top Speakers, Brands Commit to SCBIO 2017 - SC Governor McMaster to Keynote Life Sciences Conference
Frost & Sullivan Recognizes Acelity as a Leader in the Field with its New V.A.C.ULTA™ 4 Therapy System and V.A.C. VERAFLO CLEANSE CHOICE™ Dressing
Frost & Sullivan Recognizes Ventec Life Systems for New Product Innovation - Game-changing, Modular Respiratory System, VOCSN
BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis
GE Healthcare Advances the Delivery of Cell Therapies with New Thawing Technology
Ansell Limited Announces the Closing of the Sale of its Sexual Wellness Business
PQ Bypass Earns Frost & Sullivan’s European Technology Innovation Award for its Proprietary DETOUR System for Percutaneous Bypass
Curaçao EMS Uses ZOLL Autopulse to Save Tourist in Sudden Cardiac Arrest
ZOLL to Showcase Expanded Portfolio of AEDs at Caravan Salon 2017
MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®
MVZ Dr. Stein & Kollegen First German Medical Laboratory to Offer the SelectMDx for Prostate Cancer Test
Datalogic Announces New Healthcare Memor X3 HC Mobile Computer
Neuronix Ltd Announces the First Group of Mild to Moderate Alzheimer Patients to be Successfully Treated by The NeuroAD™ Therapy System

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business



Visit  La Bella Bakery Artisan Bakery Arizona

  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (